When vitamin E deficiency arises in the setting of severe cholestasis or a genetic disorder that impairs fat absorption, the usual oral route for supplementation may fail to correct the deficiency. These conditions share a common barrier: profoundly reduced intestinal uptake of fat-soluble vitamins.
This protocol targets patients with vitamin E deficiency in whom absorption through the gut is severely compromised — specifically those with severe cholestasis or an underlying genetic condition affecting fat absorption. In both contexts, enteral delivery of fat-soluble vitamins is unreliable, and an alternative approach is required.
The regimen in this scenario relies on a parenteral route of vitamin E administration. The complete protocol covers indication thresholds, monitoring parameters, and the full structured approach — see below for access.
DOI: 10.13140/RG.2.2.33351.10406
Intramuscular vitamin E: May be required in cases of severe cholestasis or genetic conditions affecting fat absorption, although it is not widely available.
View source ↗